Methods for Characterization of Senescent Circulating and Tumor-Infiltrating T-Cells: An Overview from Multicolor Flow Cytometry to Single-Cell RNA Sequencing
- PMID: 34053052
- DOI: 10.1007/978-1-0716-1507-2_6
Methods for Characterization of Senescent Circulating and Tumor-Infiltrating T-Cells: An Overview from Multicolor Flow Cytometry to Single-Cell RNA Sequencing
Abstract
Immunosenescence is the general term used to describe the aging-associated decline of immunological function that explains the higher susceptibility to infectious diseases and cancer, increased autoimmunity, or the reduced effectiveness of vaccinations. Senescence of CD8+ T-cells has been described in all these conditions.The most important classical markers of T senescent cells are the cell cycle inhibitors p16ink4a, p21, and p53, together with positivity for SA-βgal expression and the acquirement of a peculiar IFNγ -based secretory phenotype commonly defined SASP (Senescence Associated Secretory Phenotype). Other surface markers are the CD28 and CD27 loss together with gain of expression of CD45RA, CD57, TIGIT, and/or KLRG1. However, this characterization could not be sufficient to distinguish from truly senescent cells and exhausted T-cells. Furthermore, more complexity is added by the wide heterogeneity of T-cells subset in aged individuals or in the tumor microenvironment. A combined analysis by multicolor flow cytometry for surface and intracellular markers integrated with gene-expression arrays and single-cell RNA sequencing is required to develop effective interventions for therapeutic modulation of specific T-cell subsets. The RNASeq offers the great possibility to reveal at single-cell resolution the exact molecular hallmarks of senescent CD8+ T-cells without the limitations of bulk analysis. Furthermore, the comprehensive integration of multidimensional approaches (genomics, epigenomics, proteomics, metabolomics) will increase our global understanding of how immunosenescence of T-cells is interlinked to human aging.
Keywords: CD28 negative cells; CD45RA; Immunosenescence; KLRG-1; Multicolor flow cytometry; Senescence Associated Secretory Phenotype; Single-cell RNA sequencing; T-cell exhaustion; p16inka.
Similar articles
-
Polyfunctional KLRG-1+CD57+ Senescent CD4+ T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients.Front Immunol. 2021 Jul 27;12:713132. doi: 10.3389/fimmu.2021.713132. eCollection 2021. Front Immunol. 2021. PMID: 34386013 Free PMC article.
-
Cellular aging and senescence characteristics of human T-lymphocytes.Biogerontology. 2012 Apr;13(2):169-81. doi: 10.1007/s10522-011-9366-z. Epub 2011 Nov 19. Biogerontology. 2012. PMID: 22102004
-
Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans.Aging Cell. 2021 May;20(5):e13344. doi: 10.1111/acel.13344. Epub 2021 May 3. Aging Cell. 2021. PMID: 33939265 Free PMC article.
-
Are immunosenescent T cells really senescent?Aging Cell. 2024 Oct;23(10):e14300. doi: 10.1111/acel.14300. Epub 2024 Aug 7. Aging Cell. 2024. PMID: 39113243 Free PMC article. Review.
-
The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology.Int J Mol Sci. 2019 Jun 8;20(11):2810. doi: 10.3390/ijms20112810. Int J Mol Sci. 2019. PMID: 31181772 Free PMC article. Review.
Cited by
-
COVID-19 and cellular senescence.Nat Rev Immunol. 2023 Apr;23(4):251-263. doi: 10.1038/s41577-022-00785-2. Epub 2022 Oct 5. Nat Rev Immunol. 2023. PMID: 36198912 Free PMC article. Review.
-
High percentage of bone marrow CD8+ tissue-resident-like memory T cells predicts inferior survival in patients with acute myeloid leukemia.Blood Sci. 2024 Jun 7;6(3):e00194. doi: 10.1097/BS9.0000000000000194. eCollection 2024 Jul. Blood Sci. 2024. PMID: 38854481 Free PMC article.
-
The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations.Cells. 2022 Nov 29;11(23):3818. doi: 10.3390/cells11233818. Cells. 2022. PMID: 36497078 Free PMC article. Review.
-
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies.Curr Opin Neurol. 2021 Dec 1;34(6):827-833. doi: 10.1097/WCO.0000000000000988. Curr Opin Neurol. 2021. PMID: 34569985 Free PMC article. Review.
References
-
- Klebanoff CA, Gattinoni L, Restifo NP (2012) Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? J Immunother 35:651–660. https://doi.org/10.1097/CJI.0b013e31827806e6 - DOI - PubMed - PMC
-
- Larbi A, Fulop T (2014) From “truly naïve” to “exhausted senescent” T cells: when markers predict functionality. Cytom Part A 85:25–35 - DOI
-
- Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol 22:745–763 - DOI
-
- Venet F, Lepape A, Monneret G (2011) Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit Care 15(5):231. https://doi.org/10.1186/cc10333
-
- Pangrazzi L, Weinberger B (2020) T cells, aging and senescence. Exp Gerontol 134
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous